EU supports emergency use of Covid pills — RT World News

With the surge in cases across the European continent, the European Union’s drug regulatory agency supports the emergency use of Merck’s pills to treat clinically vulnerable Covid-19 patients.

On Friday, the European Medicines Agency (EMA)”Opinion issuedSupport the emergency use of the drug developed by Merck and Ridgeback Biotherapeutics, although it has not yet been authorized by the national authorities.

In a statement, the drug regulator stated that the drug called Lagevrio-also known as Monupiravir or MK 4482-“It can be used to treat adults with Covid-19 who do not need supplemental oxygen and are at increased risk of severe Covid-19.

It said that treatment should be given as soon as possible after the diagnosis of Covid-19 and within five days of the onset of symptoms. The medicine should be taken twice a day for five days.

EMA lists potential side effects of capsules, including mild or moderate diarrhea, nausea, dizziness, and headache. This treatment is not recommended for pregnant women.

The regulator announced earlier on Friday that it has begun reviewing Pfizer’s Covid-19 drug Paxlovid with the same goal.”Support national authorities“In view of the increasing number of cases and deaths in Europe, who may decide whether to use it in advance before obtaining marketing authorization.

On Friday, Austria announced that it would implement a new national lockdown and mandatory vaccination from Monday, while the German health authorities claimed that the country has become “A big explosion. “

Both Pfizer and Merck have applied to the U.S. Food and Drug Administration for approval of their coronavirus drugs, but it is unclear when they will be approved.

Do you think your friends will be interested? Share this story!

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *